The IgH 3’ regulatory region and c-myc-induced B-cell lymphomagenesis

Nour Ghazzaui; Alexis Saintamand; Hussein Issaoui; Christelle Vincent-Fabert; Yves Denizot

doi:10.18632/oncotarget.12535

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

The IgH 3’ regulatory region and c-myc-induced B-cell lymphomagenesis

Nour Ghazzaui, Alexis Saintamand, Hussein Issaoui, Christelle Vincent-Fabert and Yves Denizot _

PDF | HTML | How to cite

Oncotarget. 2017; 8:7059-7067. https://doi.org/10.18632/oncotarget.12535

Metrics: PDF 2493 views | HTML 3018 views | ?

Abstract

Nour Ghazzaui1,*, Alexis Saintamand1,*, Hussein Issaoui1, Christelle Vincent-Fabert1 and Yves Denizot1

1 Université de Limoges, Centre National de la Recherche Scientifique, CNRS UMR, France

* These authors have have contributed equally to this work

Correspondence to:

Yves Denizot, email:

Keywords: c-myc, 3’ regulatory region, lymphomagenesis, transgenic mice, HDAC

Received: August 15, 2016 Accepted: October 05, 2016 Published: October 08, 2016

Abstract

Deregulation and mutations of c-myc have been reported in multiple mature B-cell malignancies such as Burkitt lymphoma, myeloma and plasma cell lymphoma. After translocation into the immunoglobulin heavy chain (IgH) locus, c-myc is constitutively expressed under the control of active IgH cis-regulatory enhancers. Those located in the IgH 3’ regulatory region (3’RR) are master control elements of transcription. Over the past decade numerous convincing demonstrations of 3’RR’s contribution to mature c-myc-induced lymphomagenesis have been made using transgenic models with various types of IgH-c-myc translocations and transgenes. This review highlights how IgH 3’RR physiological functions play a critical role in c-myc deregulation during lymphomagenesis.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 12535

Publication Alerts

Post-Publication Promotion

Reviews:

The IgH 3’ regulatory region and c-myc-induced B-cell lymphomagenesis

Abstract